Media Outlets Cover Range Of Issues Related To Coronavirus Vaccine Development, Distribution Plans

AP: Extra safety scrutiny planned as virus vaccine worries grow (Neergaard et al., 10/14).

AP: Russia approves 2nd virus vaccine after early trials (Litvinova, 10/14).

BBC: Coronavirus: YouTube bans misleading Covid-19 vaccine videos (Criddle, 10/14).

CNBC: Healthy young people might not be able to get the coronavirus vaccine until 2022, WHO says (Feurer, 10/14).

The Guardian: Nobel laureates call on U.K. to back infecting volunteers with Covid for vaccine trials (Grover, 10/14).

The Hill: Pfizer gets approval to enroll children older than 12 in coronavirus vaccine trial (Castronuovo, 10/14).

New York Times: 3 Covid-19 Trials Have Been Paused for Safety. That’s a Good Thing (Zimmer, 10/14).

NPR: Putin Announces Approval Of A Second Unproven Coronavirus Vaccine (Neuman, 10/14).

Science: Early approval of a COVID-19 vaccine could stymie the hunt for better ones (Cohen, 10/14).

Wall Street Journal: China Drugmaker Gives Unproven Covid-19 Vaccine to Students Going Abroad (Deng, 10/14).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.